Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Cited by (1,093)

Items 101–200 of 1,093

1. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
   Skyler, Jay S., Bergenstal, Richard, Bonow, Robert O., Buse, John, Deedwania, Prakash, Gale, Edwin A.M., Howard, Barbara V., Kirkman, M. Sue, Kosiborod, Mikhail, Reaven, Peter et al. · 2009 · Diabetes Care
2. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
   Ralph A. DeFronzo · 2010 · Diabetologia
3. Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY
   Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel E. Dagogo-Jack, Ralph A. DeFronzo, DANIEL F. EINHORN, Vivian Andrew Fonseca et al. · 2016 · Endocrine Practice
4. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
   Currie, Craig J, Peters, John R, Tynan, Aodán, Evans, Marc, Heine, Robert J, Bracco, Oswaldo L, Zagar, Tony, Poole, Chris D · 2010 · The Lancet
5. 6. Glycemic Targets: <i>Standards of Medical Care in Diabetes—2021</i>
   American Diabetes Association · 2021 · Diabetes Care
6. Insulin resistance and hyperglycaemia in cardiovascular disease development
   Markku Laakso, Johanna Kuusisto · 2014 · Nature Reviews Endocrinology
7. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
   Fihn, Stephan D., Gardin, Julius M., Abrams, Jonathan, Berra, Kathleen, Blankenship, James C., Dallas, Apostolos P., Douglas, Pamela S., Foody, JoAnne M., Gerber, Thomas C., Hinderliter, Alan L. et al. · 2012 · Circulation
8. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
   Boussageon, R., Bejan-Angoulvant, T., Saadatian-Elahi, M., Lafont, S., Bergeonneau, C., Kassai, B., Erpeldinger, S., Wright, J. M., Gueyffier, F., Cornu, C. · 2011 · BMJ
9. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary
   Thomas G. Brott, Jonathan L. Halperin, Suhny Abbara, J. Michael Bacharach, John Dean Barr, Ruth L. Bush, Christopher U. Cates, Mark A. Creager, Susan A. Fowler, Gary H. Friday et al. · 2011 · Circulation
10. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): A randomised, open-label, phase 3b trial
    Pratley, Richard E, Aroda, Vanita R, Lingvay, Ildiko, Lüdemann, Jörg, Andreassen, Camilla, Navarria, Andrea, Viljoen, Adie · 2018 · The Lancet Diabetes &amp; Endocrinology
11. Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes&lt;subtitle&gt;A Randomized Controlled Trial&lt;/subtitle&gt;
    Ogawa, Hisao · 2008 · JAMA
12. The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
    Singh, Gitanjali M., Danaei, Goodarz, Farzadfar, Farshad, Stevens, Gretchen A., Woodward, Mark, Wormser, David, Kaptoge, Stephen, Whitlock, Gary, Qiao, Qing, Lewington, Sarah et al. · 2013 · PLoS ONE
13. An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
    Nicholas M. Selby, Maarten W. Taal · 2020 · Diabetes Obesity and Metabolism
14. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links.
    Oluwafemi Omoniyi Oguntibeju · 2019 · Europe PMC (PubMed Central)
15. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2018
    American Diabetes Association · 2017 · Diabetes Care
16. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
    Chan, Juliana C N, Lim, Lee-Ling, Wareham, Nicholas J, Shaw, Jonathan E, Orchard, Trevor J, Zhang, Ping, Lau, Eric S H, Eliasson, Björn, Kong, Alice P S, Ezzati, Majid et al. · 2020 · The Lancet
17. Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
    Larry B. Goldstein, Cheryl Bushnell, Robert J. Adams, Lawrence J. Appel, Lynne T. Braun, Seemant Chaturvedi, Mark A. Creager, Antonio Culebras, Robert H. Eckel, Robert G. Hart et al. · 2011 · Stroke
18. 6. Glycemic Targets: <i>Standards of Medical Care in Diabetes—2020</i>
    American Diabetes Association · 2020 · Diabetes Care
19. Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial
    Scirica, Benjamin M., Braunwald, Eugene, Raz, Itamar, Cavender, Matthew A., Morrow, David A., Jarolim, Petr, Udell, Jacob A., Mosenzon, Ofri, Im, KyungAh, Umez-Eronini, Amarachi A. et al. · 2014 · Circulation
20. The barrier of hypoglycemia in diabetes
    Cryer, Philip E. · 2008 · Diabetes
21. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus
    Sacks, David B., Arnold, Mark, Bakris, George L., Bruns, David E., Horvath, Andrea Rita, Kirkman, M. Sue, Lernmark, Ake, Metzger, Boyd E., Nathan, David M. · 2011 · Diabetes Care
22. Effect of a Low–Glycemic Index or a High–Cereal Fiber Diet on Type 2 Diabetes: A Randomized Trial
    Jenkins, David J. A., Kendall, Cyril W. C., McKeown-Eyssen, Gail, Josse, Robert G., Silverberg, Jay, Booth, Gillian L., Vidgen, Edward, Josse, Andrea R., Nguyen, Tri H., Corrigan, Sorcha et al. · 2008 · JAMA
23. Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise
    Ele Ferrannini, Silvia Jimenez Ramos, Afshin Salsali, Weihua Tang, James F. List · 2010 · Diabetes Care
24. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC study 30-year follow-up
    The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group · 2016 · Diabetes Care
25. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
    Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., Zinman, B. · 2009 · Diabetologia
26. Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)
    Ursula Margarethe Schmidt-Erfurth, José García‐Arumí, Francesco Maria Bandello, Karina Berg, Usha Chakravarthy, Bianca S. Gerendas, Jost Bruno Jonas, Michael Larsen, Ramin Tadayoni, Anat Loewenstein · 2017 · Ophthalmologica
27. Type 2 diabetes mellitus and heart failure: A position statement from the Heart Failure Association of the European Society of Cardiology
    Seferović, Petar M., Petrie, Mark C., Filippatos, Gerasimos S., Anker, Stefan D., Rosano, Giuseppe, Bauersachs, Johann, Paulus, Walter J., Komajda, Michel, Cosentino, Francesco, de Boer, Rudolf A. et al. · 2018 · European Journal of Heart Failure
28. Stroke
    Nina A. Hilkens, Barbara Casolla, Thomas Wai Hong Leung, Frank‐Erik de Leeuw · 2024 · The Lancet
29. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure
    Ezekowitz, Justin A., O'Meara, Eileen, McDonald, Michael A., Abrams, Howard, Chan, Michael, Ducharme, Anique, Giannetti, Nadia, Grzeslo, Adam, Hamilton, Peter G., Heckman, George A. et al. · 2017 · Canadian Journal of Cardiology
30. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
    Joep Perk, Guy De Backer, H. Gohlke, Ian M Graham, Željko Reiner, W. M. Monique Verschuren, Christian Albus, Pascale Benlian, Gudrun Boysen, Renata Cífková et al. · 2012 · Atherosclerosis
31. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
    Xi Lu, Qingxing Xie, Xiaohui Pan, Ruining Zhang, Xinyi Zhang, Ge Peng, Yuwei Zhang, Sumin Shen, Nanwei Tong · 2024 · Signal Transduction and Targeted Therapy
32. Trends in diabetes treatment and control in U.S. adults, 1999-2018
    Fang, Michael, Wang, Dan, Coresh, Josef, Selvin, Elizabeth · 2021 · New England Journal of Medicine
33. Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis
    Maruthur, Nisa M., Tseng, Eva, Hutfless, Susan, Wilson, Lisa M., Suarez-Cuervo, Catalina, Berger, Zackary, Chu, Yue, Iyoha, Emmanuel, Segal, Jodi B., Bolen, Shari · 2016 · Annals of Internal Medicine
34. 6. Glycemic Targets: <i>Standards of Care in Diabetes—2023</i>
    ElSayed, Nuha A., Aleppo, Grazia, Aroda, Vanita R., Bannuru, Raveendhara R., Brown, Florence M., Bruemmer, Dennis, Collins, Billy S., Hilliard, Marisa E., Isaacs, Diana, Johnson, Eric L. et al. · 2023 · Diabetes Care
35. The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension
    Stella Styliani Daskalopoulou, Doreen M. Rabi, Kelly B. Zarnke, Kaberi Dasgupta, Kara A. Nerenberg, Lyne Cloutier, Mark Gelfer, Maxime Lamarre-Cliché, Alain Milot, Peter Bolli et al. · 2015 · Canadian Journal of Cardiology
36. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
    Del Prato, Stefano, Kahn, Steven E, Pavo, Imre, Weerakkody, Govinda J, Yang, Zhengyu, Doupis, John, Aizenberg, Diego, Wynne, Alan G, Riesmeyer, Jeffrey S, Heine, Robert J et al. · 2021 · The Lancet
37. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes
    Hayward, Rodney A., Reaven, Peter D., Wiitala, Wyndy L., Bahn, Gideon D., Reda, Domenic J., Ge, Ling, McCarren, Madeline, Duckworth, William C., Emanuele, Nicholas V. · 2015 · New England Journal of Medicine
38. Update on the treatment of type 2 diabetes mellitus
    Marín-Peñalver, Juan José, Martín-Timón, Iciar, Sevillano-Collantes, Cristina, Cañizo-Gómez, Francisco Javier del · 2016 · World Journal of Diabetes
39. Heart Failure in Type 2 Diabetes Mellitus
    Helena Kenny, E. Dale Abel · 2019 · Circulation Research
40. 6. Glycemic Targets: <i>Standards of Medical Care in Diabetes—2019</i>
    American Diabetes Association · 2019 · Diabetes Care
41. Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
    Dunlay, Shannon M., Givertz, Michael M., Aguilar, David, Allen, Larry A., Chan, Michael, Desai, Akshay S., Deswal, Anita, Dickson, Victoria Vaughan, Kosiborod, Mikhail N., Lekavich, Carolyn L. et al. · 2019 · Circulation
42. Epidemiology of haemodialysis outcomes
    Aminu K. Bello, Ikechi Gareth Okpechi, Mohamed A. Osman, Yeoungjee Cho, Htay Htay, Vivekanand Jha, Marina Wainstein, David Wayne Johnson · 2022 · Nature Reviews Nephrology
43. Mitochondrial dysfunction in diabetic kidney disease
    Josephine Maree Forbes, David R. Thorburn · 2018 · Nature Reviews Nephrology
44. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes
    Zoungas, Sophia, Chalmers, John, Neal, Bruce, Billot, Laurent, Li, Qiang, Hirakawa, Yoichiro, Arima, Hisatomi, Monaghan, Helen, Joshi, Rohina, Colagiuri, Stephen et al. · 2014 · New England Journal of Medicine
45. American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 — Executive Summary
    Yehuda Handelsman, Zachary T. Bloomgarden, George Grunberger, Guillermo E. Umpierrez, Robert S. Zimmerman, Timothy Silleck Bailey, Lawrence Blonde, George A. Bray, A. Jay Cohen, Samuel E. Dagogo-Jack et al. · 2015 · Endocrine Practice
46. Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes
    James J. Chamberlain, Andrew S. Rhinehart, Charles F. Shaefer, Annie Neuman · 2016 · Annals of Internal Medicine
47. Epigenetics: a molecular link between environmental factors and type 2 diabetes
    Ling, Charlotte, Groop, Leif · 2009 · Diabetes
48. Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005
    Sarah R. Preis, Shih‐Jen Hwang, Sean Coady, Michael J. Pencina, Ralph B. D’Agostino, Peter J. Savage, Daniel A Levy, Caroline S. Fox · 2009 · Circulation
49. Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)
    JBS3 Board · 2014 · Heart
50. Clinical Inertia in People With Type 2 Diabetes
    Kamlesh Khunti, Michael Lyng Wolden, Brian Larsen Thorsted, Marc Andersen, Melanie Jane Davies · 2013 · Diabetes Care
51. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease
    John J. Ricotta, Ali F. AbuRahma, Enrico Ascher, Mark K. Eskandari, Peter L. Faries, Brajesh K. Lal · 2011 · Journal of Vascular Surgery
52. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary
    Garber, Alan J., Handelsman, Yehuda, Grunberger, George, Einhorn, Daniel, Abrahamson, Martin J., Barzilay, Joshua I., Blonde, Lawrence, Bush, Michael A., DeFronzo, Ralph A., Garber, Jeffrey R. et al. · 2020 · Endocrine Practice
53. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
    Ralph Anthony DeFronzo, William Brian Reeves, Alaa S. Awad · 2021 · Nature Reviews Nephrology
54. Endothelial Cell Metabolism
    Guy Eelen, Pauline de Zeeuw, Lucas Treps, Ulrike Harjes, Brian W. Wong, Peter Carmeliet · 2017 · Physiological Reviews
55. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
    Virani, Salim S., Newby, L. Kristin, Arnold, Suzanne V., Bittner, Vera, Brewer, LaPrincess C., Demeter, Susan Halli, Dixon, Dave L., Fearon, William F., Hess, Beverly, Johnson, Heather M. et al. · 2023 · Journal of the American College of Cardiology
56. The ABC transporter structure and mechanism: perspectives on recent research
    Peter M. Jones, Anthony M. George · 2004 · Cellular and Molecular Life Sciences
57. Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications
    Corey E. Tabit, William B. Chung, Naomi M. Hamburg, Joseph A. Vita · 2010 · Reviews in Endocrine and Metabolic Disorders
58. Efficacy and safety of degludec versus glargine in type 2 diabetes.
    Marso, Steven P., McGuire, Darren K., Zinman, Bernard, Poulter, Neil R., Emerson, Scott S., Pieber, Thomas R., Pratley, Richard E., Haahr, Poul-Martin, Lange, Martin, Brown-Frandsen, Kirstine et al. · 2017 · New England Journal of Medicine
59. American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015
    Handelsman, Yehuda, Bloomgarden, Zachary T., Grunberger, George, Umpierrez, Guillermo, Zimmerman, Robert S., Bailey, Timothy S., Blonde, Lawrence, Bray, George A., Cohen, A. Jay, Dagogo-Jack, Samuel et al. · 2015 · Endocrine Practice
60. Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
    Di Pino, Antonino, DeFronzo, Ralph A · 2019 · Endocrine Reviews
61. Impact of diabetes on cardiovascular disease: an update
    Matheus, Alessandra Saldanha de Mattos, Tannus, Lucianne Righeti Monteiro, Cobas, Roberta Arnoldi, Palma, Catia C. Sousa, Negrato, Carlos Antonio, Gomes, Marilia de Brito · 2013 · International Journal of Hypertension
62. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
    Ralph Anthony DeFronzo, Luke Norton, Muhammad A Abdul‐Ghani · 2016 · Nature Reviews Nephrology
63. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
    Frank L.J. Visseren, François Mach, Yvo Michiel Smulders, David Carballo, Konstantinos C. Koskinas, Maria Bäck, Athanase Bénétos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno et al. · 2021 · European Journal of Preventive Cardiology
64. Japanese clinical practice guideline for diabetes 2019
    Araki, Eiichi, Goto, Atsushi, Kondo, Tatsuya, Noda, Mitsuhiko, Noto, Hiroshi, Origasa, Hideki, Osawa, Haruhiko, Taguchi, Akihiko, Tanizawa, Yukio, Tobe, Kazuyuki et al. · 2020 · Diabetology International
65. Diabetes in Older Adults: A Consensus Report
    Sue Kirkman, M., Briscoe, Vanessa Jones, Clark, Nathaniel, Florez, Hermes, Haas, Linda B., Halter, Jeffrey B., Huang, Elbert S., Korytkowski, Mary T., Munshi, Medha N., Odegard, Peggy Soule et al. · 2012 · Journal of the American Geriatrics Society
66. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
    Amiel, Stephanie A, Aschner, Pablo, Childs, Belinda, Cryer, Philip E, de Galan, Bastiaan E, Frier, Brian M, Gonder-Frederick, Linda, Heller, Simon R, Jones, Timothy, Khunti, Kamlesh et al. · 2019 · The Lancet Diabetes &amp; Endocrinology
67. Increased mortality of patients with diabetes reporting severe hypoglycemia
    McCoy, Rozalina G., Van Houten, Holly K., Ziegenfuss, Jeanette Y., Shah, Nilay D., Wermers, Robert A., Smith, Steven A. · 2012 · Diabetes Care
68. Hyperglycemia Induces a Dynamic Cooperativity of Histone Methylase and Demethylase Enzymes Associated With Gene-Activating Epigenetic Marks That Coexist on the Lysine Tail
    Daniella Brasacchio, Jun Okabe, Christos Tikellis, Aneta Balcerczyk, Prince George, Emma K. Baker, Anna C. Calkin, Michael Brownlee, Mark Emmanuel Cooper, Assam El‐Osta · 2009 · Diabetes
69. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
    Zoungas, Sophia, Arima, Hisatomi, Gerstein, Hertzel C, Holman, Rury R, Woodward, Mark, Reaven, Peter, Hayward, Rodney A, Craven, Timothy, Coleman, Ruth L, Chalmers, John · 2017 · The Lancet Diabetes &amp; Endocrinology
70. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary
    Thomas G. Brott, Jonathan L. Halperin, Suhny Abbara, J. Michael Bacharach, John Dean Barr, Ruth L. Bush, Christopher U. Cates, Mark A. Creager, Susan A. Fowler, Gary H. Friday et al. · 2011 · Journal of the American College of Cardiology
71. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association
    Biykem Bozkurt, David A. Aguilar, Anita M Deswal, Sandra Barker Dunbar, Gary S. Francis, Tamara B. Horwich, Mariell L Jessup, Mikhail Kosiborod, Allison M. Pritchett, Kumudha Ramasubbu et al. · 2016 · Circulation
72. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
    Eugene J. Barrett, Zhenqi Liu, Mogher Khamaisi, George Liang King, Ronald Klein, Ronald Klein, Timothy M. Hughes, Suzanne Craft, Barry I. Freedman, Donald W. Bowden et al. · 2017 · The Journal of Clinical Endocrinology & Metabolism
73. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
    Blonde, Lawrence, Umpierrez, Guillermo E., Reddy, S. Sethu, McGill, Janet B., Berga, Sarah L., Bush, Michael, Chandrasekaran, Suchitra, DeFronzo, Ralph A., Einhorn, Daniel, Galindo, Rodolfo J. et al. · 2022 · Endocrine Practice
74. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
    Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel E. Dagogo-Jack, Ralph A. DeFronzo, DANIEL F. EINHORN, Vivian Andrew Fonseca et al. · 2018 · Endocrine Practice
75. Severe hypoglycaemia and cardiovascular disease: Systematic review and meta-analysis with bias analysis
    Goto, A., Arah, O. A., Goto, M., Terauchi, Y., Noda, M. · 2013 · BMJ
76. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
    for the ADVANCE Collaborative group, Sophia Zoungas, Mark Woodward, Qiang Li, Mark Emmanuel Cooper, Pavel Hamet, Stephen B. Harrap, Simon R. Heller, Michel Marre, Anushka A Patel et al. · 2014 · Diabetologia
77. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
    Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay et al. · 2023 · Diabetes Care
78. Comorbidities of Diabetes and Hypertension: Mechanisms and Approach to Target Organ Protection
    Amanda N. Long, Samuel E. Dagogo-Jack · 2011 · Journal of Clinical Hypertension
79. The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia
    Ralph Anthony DeFronzo, Jaime A. Davidson, Stefano Del Prato · 2011 · Diabetes Obesity and Metabolism
80. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
    Caroline S. Fox, Sherita Hill Golden, Cheryl A.M. Anderson, George A. Bray, Lora E. Burke, Ian H. de Boer, PRAKASH C. DEEDWANIA, Robert H. Eckel, Abby G. Ershow, JUDITH E. FRADKIN et al. · 2015 · Diabetes Care
81. 2016 European Guidelines on cardiovascular disease prevention in clinical practice
    Massimo Francesco Piepoli, Arno Wilhelmus Hoes, Stefan Agewall, Christian Albus, Carlos Brotons, Alberico Luigi Catapano, Marie Therese Cooney, Ugo Corrà, Bernard Cosyns, Christi Deaton et al. · 2016 · Atherosclerosis
82. GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
    Nikolaus Marx, Mansoor Husain, Michael Lehrke, Subodh Verma, Naveed A. Sattar · 2022 · Circulation
83. Receptor for AGE (RAGE): Signaling mechanisms in the pathogenesis of diabetes and its complications
    Ramasamy, Ravichandran, Yan, Shi Fang, Schmidt, Ann Marie · 2011 · Annals of the New York Academy of Sciences
84. Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications
    Eleftheria Papachristoforou, Vaia Lambadiari, Eirini Maratou, Konstantinos Makrilakis · 2020 · Journal of Diabetes Research
85. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
    Das, Sandeep R., Everett, Brendan M., Birtcher, Kim K., Brown, Jenifer M., Januzzi, James L., Kalyani, Rita R., Kosiborod, Mikhail, Magwire, Melissa, Morris, Pamela B., Neumiller, Joshua J. et al. · 2020 · Journal of the American College of Cardiology
86. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications
    Brian M. Frier · 2014 · Nature Reviews Endocrinology
87. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations
    Bennett, Wendy L., Maruthur, Nisa M., Singh, Sonal, Segal, Jodi B., Wilson, Lisa M., Chatterjee, Ranee, Marinopoulos, Spyridon S., Puhan, Milo A., Ranasinghe, Padmini, Block, Lauren et al. · 2011 · Annals of Internal Medicine
88. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
    Jay S. Skyler, Richard M. Bergenstal, Robert O. Bonow, John B. Buse, PRAKASH C. DEEDWANIA, Edwin AM Gale, Barbara V. Howard, Marian Sue Kirkman, Mikhail Kosiborod, Peter D. Reaven et al. · 2009 · Journal of the American College of Cardiology
89. Primary prevention of cardiovascular disease: A review of contemporary guidance and literature
    Jack Stewart, Gavin Paul Raphael Manmathan, Peter Wilkinson · 2017 · JRSM Cardiovascular Disease
90. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia
    Fruchart, Jean-Charles, Sacks, Frank, Hermans, Michel P., Assmann, Gerd, Brown, W. Virgil, Ceska, Richard, Chapman, M. John, Dodson, Paul M., Fioretto, Paola, Ginsberg, Henry N. et al. · 2008 · The American Journal of Cardiology
91. State of the art paper Sulfonylureas and their use in clinical practice
    Sola, Daniele, Rossi, Luca, Schianca, Gian Piero Carnevale, Maffioli, Pamela, Bigliocca, Marcello, Mella, Roberto, Corlianò, Francesca, Fra, Gian Paolo, Bartoli, Ettore, Derosa, Giuseppe · 2015 · Archives of Medical Science
92. Diabetes, hyperglycaemia, and acute ischaemic stroke
    Merel J.A. Luitse, Geert Jan Biessels, Guy E.H.M. Rutten, Laurens Jaap Kappelle · 2012 · The Lancet Neurology
93. Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk
    Chia, Chee W., Egan, Josephine M., Ferrucci, Luigi · 2018 · Circulation Research
94. Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
    Pop-Busui, Rodica, Evans, Gregory W., Gerstein, Hertzel C., Fonseca, Vivian, Fleg, Jerome L., Hoogwerf, Byron J., Genuth, Saul, Grimm, Richard H., Corson, Marshall A., Prineas, Ronald et al. · 2010 · Diabetes Care
95. Metformin and inflammation: its potential Beyond glucose-lowering effect
    Saisho, Yoshifumi · 2015 · Endocrine, Metabolic &amp; Immune Disorders-Drug Targets
96. Adherence to diabetes medication: a systematic review
    Ines Krass, P. Schieback, Teerapon Dhippayom · 2014 · Diabetic Medicine
97. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes
    Aronsohn, Renee S., Whitmore, Harry, Van Cauter, Eve, Tasali, Esra · 2010 · American Journal of Respiratory and Critical Care Medicine
98. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease
    Thomas G. Brott, Jonathan L. Halperin, Suhny Abbara, J. Michael Bacharach, John Dean Barr, Ruth L. Bush, Christopher U. Cates, Mark A. Creager, Susan A. Fowler, Gary H. Friday et al. · 2011 · Journal of the American College of Cardiology
99. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database
    Tzoulaki, I., Molokhia, M., Curcin, V., Little, M. P, Millett, C. J, Ng, A., Hughes, R. I, Khunti, K., Wilkins, M. R, Majeed, A. et al. · 2009 · BMJ
100. Rates of Complications and Mortality in Older Patients With Diabetes Mellitus: The Diabetes and Aging Study
     Huang, Elbert S., Laiteerapong, Neda, Liu, Jennifer Y., John, Priya M., Moffet, Howard H., Karter, Andrew J. · 2014 · JAMA Internal Medicine